A1C Converter: Blood Glucose, eAG, and Fructosamine Conversion Guide
You check your blood sugar at home. You see a number, maybe 150 mg/dL or 180 mg/dL. Your doctor, though, always talks about your A1C. What connects the two?
This A1C converter translates between the numbers you see every day and the number your doctor tracks every few months. Use it to convert blood glucose to A1C, convert A1C to estimated average glucose (eAG), switch between NGSP percent and IFCC mmol/mol, or convert fructosamine to A1C when you need a shorter-term view. Below, this guide explains what each number means, how the math works, and where the formulas break down.
A1C Converter
Convert between blood glucose, A1C, eAG, IFCC mmol/mol, and fructosamine, all in one tool.
Related Calculators
What Is A1C? Understanding Glycated Hemoglobin
A1C stands for glycated hemoglobin. You’ll also see it written as hemoglobin A1C, HbA1c, or, in older literature, glycosylated hemoglobin. All four terms describe the same lab value.
Here’s the biology in plain terms. Hemoglobin is the protein inside your red blood cells that carries oxygen. When glucose circulates in your bloodstream, some of it attaches to that hemoglobin, a process called glycation. The more glucose in your blood, the more hemoglobin becomes glycated. Your A1C percentage measures exactly this: what share of your hemoglobin molecules currently carry attached glucose.
Red blood cells live for about 120 days, or roughly three to four months. Because glycation accumulates gradually across a red blood cell’s lifespan, your A1C level reflects your average blood glucose concentration over the past two to three months, not just today’s reading. That’s why doctors order this laboratory test every three to six months rather than daily: a single high blood sugar reading might mean nothing, but a high A1C confirms your glycemic control has been consistently elevated over many weeks.
The formulas below come from the American Diabetes Association (ADA) and the NGSP (National Glycohemoglobin Standardization Program), the same standardization your lab uses to report results.
Blood Glucose to A1C Converter
You track your blood sugar with a continuous glucose monitor (CGM) or a standard meter, and you get readings in mg/dL (or mmol/L in some countries). How does that translate into an A1C percentage?
The ADA’s validated formula, based on the ADAG (A1C-Derived Average Glucose) study published by Nathan et al. in Diabetes Care (2008):
A1C (%) = (Average Blood Glucose [mg/dL] + 46.7) ÷ 28.7
Worked example: If your average blood glucose over the past few weeks runs 150 mg/dL:
A1C = (150 + 46.7) ÷ 28.7 = 196.7 ÷ 28.7 = 6.9%
That’s slightly above the ADA’s standard treatment target of 7.0% but not yet in a critical range. Enter your own average glucose above and the A1C converter returns your estimated A1C instantly.
mg/dL vs. mmol/L
Most countries measure blood glucose in mg/dL. Canada, the UK, Australia, and much of Europe use mmol/L instead. To convert between glucose units:
- mg/dL to mmol/L: divide by 18
- mmol/L to mg/dL: multiply by 18
The calculator above accepts mg/dL. If your meter or lab report shows mmol/L, convert first.
A1C to Blood Glucose (eAG) Converter
Sometimes the sequence runs the other way: you have an A1C percentage from a recent lab test and want to know what it means for your day-to-day blood sugar.
The reverse formula gives you your estimated average glucose (eAG) in mg/dL:
Estimated Average Glucose (mg/dL) = (28.7 × A1C) − 46.7
Worked example: An A1C of 7.0% converts to:
eAG = (28.7 × 7.0) − 46.7 = 200.9 − 46.7 = 154 mg/dL
Why does eAG matter? It puts your A1C result into the same units your meter or CGM already uses. Instead of thinking “my A1C is 7.0%,” you can think “my average blood sugar runs around 154 mg/dL.” That makes day-to-day diabetes management more intuitive. If your meter reads 180 mg/dL after a meal, you immediately know you’re running above a 154 mg/dL average and may need to adjust.
A1C to IFCC mmol/mol Converter
If your lab report was issued in the UK, most of Europe, or Australia, you may see your result in mmol/mol rather than a percentage. This is the IFCC (International Federation of Clinical Chemistry) standard, and it measures the same underlying glycated hemoglobin, just on a different scale than the NGSP percentage used in the US.
IFCC (mmol/mol) = (A1C% − 2.15) × 10.929
Worked example: An A1C of 7.0% converts to:
IFCC = (7.0 − 2.15) × 10.929 = 4.85 × 10.929 = 53 mmol/mol
So if your lab hands you a result of “53,” that’s the same result as 7.0%, not a different, more alarming number. This distinction trips people up regularly (it’s a common source of confusion in diabetes forums), so if your numbers look wildly different from what a US-based chart shows, check which standard your lab used before assuming your glycemic control has changed.
Fructosamine to A1C Converter: A Shorter-Term View
Fructosamine measures glycated serum proteins, mainly albumin, rather than hemoglobin. Because serum proteins circulate for only two to three weeks (not 120 days), fructosamine reflects your blood glucose control over a much shorter window than A1C does.
Estimated A1C (%) = (Fructosamine [µmol/L] ÷ 19.4) + 1.6
Worked example: A fructosamine result of 300 µmol/L converts to:
Estimated A1C = (300 ÷ 19.4) + 1.6 = 15.5 + 1.6 = 7.1%
Reverse direction: A1C to fructosamine
Estimated Fructosamine (µmol/L) = (A1C% − 1.6) × 19.4
Worked example: An A1C of 7.5% converts to:
Fructosamine = (7.5 − 1.6) × 19.4 = 5.9 × 19.4 = 286 µmol/L
This converter includes both directions. Most online tools cover only glucose-to-A1C conversion and skip fructosamine entirely.
When Doctors Use Fructosamine Instead of A1C
Doctors use a fructosamine assay in specific situations:
| Situation | Why Fructosamine Is Better |
|---|---|
|
Hemoglobin variants (sickle cell, thalassemia) |
A1C is inaccurate. Fructosamine is not affected. |
|
Anemia (iron deficiency, haemolytic anaemia) |
Red blood cell lifespan changes skew A1C. Fructosamine remains reliable. |
|
Kidney disease (CKD) |
Uremia interferes with A1C measurement. |
|
Pregnancy (gestational diabetes) |
Rapid blood volume changes affect A1C. Fructosamine tracks shorter-term changes. |
|
Recent treatment changes |
Want to see if new medication is working within weeks, not months. |
A1C Reference Range: What Your Number Means
The ADA sets clear thresholds for diagnosis and treatment. The NIDDK (National Institute of Diabetes and Digestive and Kidney Diseases) and CDC use the same standards.
| A1C Range | Classification | Clinical Action |
|---|---|---|
|
Below 5.7% |
Normal |
No diabetes, continue healthy lifestyle |
|
5.7% – 6.4% |
Prediabetes |
Lifestyle changes recommended; elevated risk of progressing to type 2 diabetes |
|
6.5% or higher |
Diabetes (diagnosis) |
Confirmed with a repeat test; treatment typically begins |
|
7.0% (ADA target) |
Treatment goal for most non-pregnant adults |
Standard target; balance benefit vs hypoglycaemia risk |
|
Below 6.5% |
Intensive target |
For younger patients with new diabetes; no significant cardiovascular disease |
|
Below 8.0% |
Less stringent target |
For older adults (65+), those with complex medical history, or limited life expectancy |
Why Targets Differ by Person
- Most non-pregnant adults with type 1 diabetes or type 2 diabetes: target below 7.0%.
- Younger patients with new-onset diabetes and no cardiovascular disease: below 6.5% is reasonable if achievable without significant hypoglycemia.
- Older adults (65+), those with long-standing diabetes, or significant comorbidities: below 8.0% may be more appropriate, since aggressive control in this group raises hypoglycemia risk without a clear added benefit.
Blood Glucose to A1C Chart
| Your A1C (%) | Your Estimated Average Glucose (mg/dL) | ADA Classification |
|---|---|---|
|
5.5% |
112 mg/dL |
Normal |
|
6.0% |
126 mg/dL |
Prediabetes threshold |
|
6.5% |
140 mg/dL |
Diabetes diagnosis |
|
7.0% |
154 mg/dL |
Standard treatment target |
|
8.0% |
183 mg/dL |
Above target |
|
9.0% |
212 mg/dL |
Poor control |
|
10.0% |
240 mg/dL |
Critical, urgent action |
Blood Glucose Thresholds (Fasting & Postprandial)
Your fasting blood glucose (measured after 8+ hours without food) and postprandial glucose (measured two hours after a meal) also help diagnose and monitor diabetes.
| Category | Fasting Glucose (mg/dL) | 2-Hour Postprandial (mg/dL) | A1C Equivalent |
|---|---|---|---|
|
Normal |
70–99 mg/dL |
Under 140 mg/dL |
Below 5.7% |
|
Impaired Fasting Glucose (Prediabetes) |
100–125 mg/dL |
140–199 mg/dL |
5.7% – 6.4% |
|
Diabetes |
126 mg/dL or higher |
200 mg/dL or higher |
6.5% or higher |
|
Hypoglycemia |
Below 70 mg/dL |
N/A |
Varies |
Severe hypoglycemia (blood glucose below 54 mg/dL) requires immediate treatment. Symptoms include confusion, shakiness, sweating, and loss of consciousness. If you experience frequent low blood sugar events, discuss whether your A1C target should be less strict.
A word of caution on averages: an A1C of 6.0% corresponds to an eAG of roughly 126 mg/dL, but if your daily readings swing widely, say from 50 mg/dL to 300 mg/dL, your average can look normal while your actual glycemic control is genuinely poor. This is one reason doctors also review time-in-range (TIR) from a continuous glucose monitor rather than relying on A1C alone; averages can hide real glucose variability.
Who Needs Different A1C Targets?
Your ideal target depends on your specific type of diabetes, your age, other medical conditions, and your hypoglycemia risk.
| Population | Recommended A1C Target | Why |
|---|---|---|
|
Adults, type 1 or type 2 diabetes (non-pregnant) |
Below 7.0% |
Standard ADA target |
|
Younger patients, new-onset, no cardiovascular disease |
Below 6.5% |
Achievable intensive control without excess hypoglycemia risk |
|
Older adults (65+) or significant comorbidities |
Below 8.0% |
Hypoglycemia risk (falls, cognitive decline) outweighs benefit of tight control |
|
Gestational diabetes |
Below 6.5%, often below 6.0% |
Rapid blood volume changes in pregnancy; fructosamine sometimes preferred |
|
Children under 6 |
Below 8.5% |
Severe hypoglycemia risk is higher; brain development unaffected by moderate hyperglycemia |
|
Children 6–12 |
Below 8.0% |
Balances development against complication risk |
|
Teenagers 13–18 |
Below 7.5% |
Hormonal changes complicate control |
Type 2 diabetes accounts for 90–95% of all diagnosed cases. Most people with type 2 diabetes still produce insulin, but their bodies show reduced insulin sensitivity, a pattern commonly called insulin resistance. If you also have significant cardiovascular disease, a less strict target (below 8.0%) may be appropriate; aggressive glycemic management hasn’t been shown to reduce heart attacks or strokes in this group.
Gestational diabetes develops during pregnancy and usually resolves after delivery, but it raises complication risk for both mother and baby, which is why targets run tighter and fructosamine is sometimes used alongside A1C for faster feedback.
Children use the same underlying formula as adults (the math doesn’t change with age), but interpreting the result requires age-specific context, so review results with a pediatric endocrinologist rather than applying adult thresholds directly.
When the A1C Formula Doesn't Apply
The A1C converter uses the ADA formula, which assumes a normal 120-day red blood cell lifespan. Several conditions break that assumption:
- Iron deficiency anemia prolongs red blood cell lifespan, giving glucose more time to attach to hemoglobin. This can artificially raise A1C by one to two full percentage points.
- Hemolytic anemia (sickle cell disease, thalassemia, spherocytosis) shortens red blood cell lifespan, giving glucose less time to attach, which can artificially lower A1C and hide poorly controlled diabetes.
- Hemoglobin variants, including sickle cell trait (present in 8-10% of African Americans), sickle cell disease, thalassemia (common in Mediterranean, Middle Eastern, and Southeast Asian populations), and hemoglobin C, D, and E traits, interfere with the lab assay itself. Results can come back falsely low, falsely high, or unreportable.
- Chronic kidney disease (CKD) affects A1C through uremia interfering with the assay, anemia of chronic disease altering red blood cell lifespan, and erythropoietin therapy shortening it further. In advanced CKD (stages 4–5), A1C may be unreliable.
- Ethnicity: some research shows A1C levels running slightly higher in people of African, Hispanic, and Asian descent than in Caucasians at the same measured blood glucose. This doesn’t mean the converter’s math is wrong; it means the diagnostic thresholds sometimes need contextual interpretation, which your doctor factors in.
- Pregnancy accelerates red blood cell turnover, which can lower A1C independent of actual glucose control. Most specialists target a lower A1C during pregnancy regardless of what a standard converter suggests.
In any of these situations, your doctor may order a fructosamine test instead, since fructosamine isn’t affected by red blood cell lifespan.
The Evidence Behind This Converter
The American Diabetes Association’s Standards of Medical Care in Diabetes, updated annually, sets the standard used across US diabetes management. The formulas on this page draw on the DCCT (Diabetes Control and Complications Trial), the landmark study that first established the relationship between A1C and long-term complication risk, and the ADAG (A1C-Derived Average Glucose) study (Nathan et al., Diabetes Care, 2008), which defined the specific mg/dL-to-percentage relationship used here. The NGSP (National Glycohemoglobin Standardization Program) standardizes how US labs report results, while the IFCC (International Federation of Clinical Chemistry) standard governs the mmol/mol units used internationally.
The ADA recommends A1C testing at least twice a year for patients meeting their treatment goals, and quarterly for anyone whose therapy has recently changed or who isn’t yet meeting glycemic targets, more frequently during pregnancy or after a significant medication change.
Frequently Asked Questions
What is my A1C if my blood sugar is 150 mg/dL?
Using the conversion formula: (150 + 46.7) ÷ 28.7 = 6.9%. That’s just above the ADA’s 7.0% treatment target.
How accurate is A1C conversion?
The eAG formula carries a margin of error of roughly ±15 mg/dL. An A1C of 7.0% corresponds to an eAG of 154 mg/dL, but your actual average glucose could fall anywhere from about 139 to 169 mg/dL. Treat the result as a reliable estimate, not an exact prediction.
Why is my A1C higher than my average glucose suggests?
A few things can cause this mismatch: iron deficiency anemia (prolongs red blood cell lifespan), kidney disease (interferes with the assay), hemoglobin variants like sickle cell trait or thalassemia, or ethnicity-related differences in how A1C tracks glucose. If you notice a consistent gap, ask your doctor about fructosamine testing or reviewing your CGM data instead.
Can fructosamine replace A1C?
Not entirely. Fructosamine reflects glucose control over two to three weeks, not two to three months, so it’s a complementary tool rather than a substitute. Use the fructosamine-to-A1C converter above when you need to translate between the two.
How often should I check my A1C?
Twice a year if you’re meeting your treatment goals; quarterly if your therapy recently changed or you’re not yet at target; more often during pregnancy or after a significant medication adjustment.
What is the difference between A1C and estimated average glucose (eAG)?
A1C is a percentage measuring what share of your hemoglobin is glycated. eAG converts that percentage into the same mg/dL (or mmol/L) units your home meter already uses. Most people find eAG more intuitive day-to-day since it matches numbers they’re already used to seeing.
How do I convert A1C to mmol/L?
First convert to eAG in mg/dL, then divide by 18. Example: A1C of 7.0% → eAG of 154 mg/dL → 154 ÷ 18 = 8.6 mmol/L.
What is IFCC mmol/mol, and why is my result showing that instead of a percentage?
IFCC mmol/mol is the international standard for reporting A1C, used across the UK, most of Europe, and Australia. It measures the same glycated hemoglobin as the US percentage system, just on a different numeric scale. An A1C of 7.0% equals 53 mmol/mol; they’re the same result, not two different readings.
What A1C corresponds to 200 mg/dL blood glucose?
Reversing the formula: (200 + 46.7) ÷ 28.7 = 8.6%.
Is there a separate A1C converter for children?
The math is identical at any age; only the clinical interpretation changes. Children with type 1 diabetes have higher recommended targets (roughly below 7.5-8.5%, depending on age) than adults (below 7.0%). Discuss any result with a pediatric endocrinologist.
What is the glycemic index, and is it the same as A1C?
No. Glycemic index measures how quickly a specific food raises blood sugar, while A1C measures your average blood glucose over months. They’re related (a diet full of high-glycemic-index foods can contribute to a higher A1C over time) but they answer different questions.
Medical Disclaimer
This A1C converter uses formulas validated by the American Diabetes Association (ADA), the NGSP, the IFCC, and the DCCT. It provides educational estimates only and is not a substitute for laboratory A1C testing, clinical diagnosis, or medical advice. Individual results can vary due to red blood cell lifespan differences (anemia, hemolytic conditions), hemoglobin variants, kidney disease, pregnancy, and ethnicity. Always discuss your A1C results with a qualified healthcare provider or endocrinologist, and do not change medication, insulin, or diet based solely on this tool. If you have type 1 diabetes, type 2 diabetes, gestational diabetes, or prediabetes, follow the monitoring and treatment plan your doctor has prescribed for you.
Sources
- American Diabetes Association. Standards of Medical Care in Diabetes (updated annually)
- Nathan DM, Kuenen J, Borg R, Zheng H, Schoenfeld D, Heine RJ. “Translating the A1C Assay into Estimated Average Glucose Values.” Diabetes Care, 2008;31(8):1473–1478 (the ADAG study)
- Diabetes Control and Complications Trial (DCCT) Research Group
- National Glycohemoglobin Standardization Program (NGSP)
- International Federation of Clinical Chemistry (IFCC)
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Centers for Disease Control and Prevention (CDC)